148 related articles for article (PubMed ID: 24829162)
1. Statins and the risk of liver injury: a population-based case-control study.
Chen GL; Hsiao FY; Dong YH; Shen LJ; Wu FL
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):719-25. PubMed ID: 24829162
[TBL] [Abstract][Full Text] [Related]
2. Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins.
García Rodríguez LA; Herings R; Johansson S
Pharmacoepidemiol Drug Saf; 2010 Dec; 19(12):1218-24. PubMed ID: 20922707
[TBL] [Abstract][Full Text] [Related]
3. The safety of rosuvastatin in comparison with other statins in over 100,000 statin users in UK primary care.
García-Rodríguez LA; Massó-González EL; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):943-52. PubMed ID: 18425988
[TBL] [Abstract][Full Text] [Related]
4. Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases.
Dormuth CR; Hemmelgarn BR; Paterson JM; James MT; Teare GF; Raymond CB; Lafrance JP; Levy A; Garg AX; Ernst P;
BMJ; 2013 Mar; 346():f880. PubMed ID: 23511950
[TBL] [Abstract][Full Text] [Related]
5. New analysis supports expanded use of statins in women.
Harv Womens Health Watch; 2010 Apr; 17(8):6. PubMed ID: 20506603
[No Abstract] [Full Text] [Related]
6. Liver toxicity of rosuvastatin therapy.
Famularo G; Miele L; Minisola G; Grieco A
World J Gastroenterol; 2007 Feb; 13(8):1286-8. PubMed ID: 17451217
[TBL] [Abstract][Full Text] [Related]
7. Statins use and female lung cancer risk in Taiwan.
Lai SW; Liao KF; Lin CL; Sung FC; Cheng YH
Libyan J Med; 2012 Dec; 7(1):1-3. PubMed ID: 23272648
[TBL] [Abstract][Full Text] [Related]
8. The safety of rosuvastatin in comparison with other statins in over 25,000 statin users in the Saskatchewan Health Databases.
García-Rodríguez LA; González-Pérez A; Stang MR; Wallander MA; Johansson S
Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):953-61. PubMed ID: 18425987
[TBL] [Abstract][Full Text] [Related]
9. Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment.
van Staa TP; Carr DF; O'Meara H; McCann G; Pirmohamed M
Br J Clin Pharmacol; 2014 Sep; 78(3):649-59. PubMed ID: 24602118
[TBL] [Abstract][Full Text] [Related]
10. Safety profile of rosuvastatin: results of a prescription-event monitoring study of 11,680 patients.
Kasliwal R; Wilton LV; Cornelius V; Aurich-Barrera B; Shakir SA
Drug Saf; 2007; 30(2):157-70. PubMed ID: 17253880
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and tolerability of every-other-day rosuvastatin dosing in patients with prior statin intolerance.
Backes JM; Venero CV; Gibson CA; Ruisinger JF; Howard PA; Thompson PD; Moriarty PM
Ann Pharmacother; 2008 Mar; 42(3):341-6. PubMed ID: 18285559
[TBL] [Abstract][Full Text] [Related]
12. Signal detection of rosuvastatin compared to other statins: data-mining study using national health insurance claims database.
Choi NK; Chang Y; Choi YK; Hahn S; Park BJ
Pharmacoepidemiol Drug Saf; 2010 Mar; 19(3):238-46. PubMed ID: 20049851
[TBL] [Abstract][Full Text] [Related]
13. Reversible acute hepatitis induced by rosuvastatin.
Oteri A; Catania MA; Russo A; Salvo F; Giacci L; Caputi AP; Polimeni G
South Med J; 2008 Jul; 101(7):768. PubMed ID: 19209117
[No Abstract] [Full Text] [Related]
14. Rosuvastatin in patients with elevated C-reactive protein.
Fugh-Berman A
N Engl J Med; 2009 Mar; 360(10):1038-9; author reply 1041-2. PubMed ID: 19271272
[No Abstract] [Full Text] [Related]
15. α1-Microglobulin/albumin ratio may improve interpretation of albuminuria in statin-treated patients.
Wehlou CM; Speeckaert MM; Fiers T; De Buyzere ML; Delanghe JR
Clin Chem Lab Med; 2013 Jul; 51(7):1529-34. PubMed ID: 23314557
[TBL] [Abstract][Full Text] [Related]
16. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
[TBL] [Abstract][Full Text] [Related]
17. Successful desensitization to rosuvastatin in a patient with a history of anaphylaxis to multiple statins.
Khan FS; Stewart DK; Brunzell JD; Natrajan KM; Castells MC; Henderson WR; Ayars AG
J Allergy Clin Immunol; 2013 Jan; 131(1):234-6. PubMed ID: 23177998
[No Abstract] [Full Text] [Related]
18. Rosuvastatin (Crestor) and rhabdomyolysis.
Wooltorton E
CMAJ; 2004 Jul; 171(2):129. PubMed ID: 15262879
[No Abstract] [Full Text] [Related]
19. Efficacy and tolerability of once-weekly rosuvastatin in patients with previous statin intolerance.
Kennedy SP; Barnas GP; Schmidt MJ; Glisczinski MS; Paniagua AC
J Clin Lipidol; 2011; 5(4):308-15. PubMed ID: 21784377
[TBL] [Abstract][Full Text] [Related]
20. Randomized dose-response study of rosuvastatin in Japanese patients with hypercholesterolemia.
Saito Y; Goto Y; Dane A; Strutt K; Raza A
J Atheroscler Thromb; 2003; 10(6):329-36. PubMed ID: 15037821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
